相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Bidirectional Role of NLRP3 During Acute and Chronic Cholestatic Liver Injury
Mick Frissen et al.
HEPATOLOGY (2021)
Histone deacetylase 8 inhibition alleviates cholestatic liver injury and fibrosis
Chang Hun Lee et al.
BIOCHEMICAL PHARMACOLOGY (2021)
Primary biliary cholangitis: pathogenesis and therapeutic opportunities
Aliya F. Gulamhusein et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2020)
Metabolic Hallmarks of Hepatic Stellate Cells in Liver Fibrosis
Olga Khomich et al.
CELLS (2020)
Obeticholic acid-a new therapy in PBC and NASH
Roger W. Chapman et al.
BRITISH MEDICAL BULLETIN (2020)
Emerging therapies in primary sclerosing cholangitis: pathophysiological basis and clinical opportunities
Mette Vesterhus et al.
JOURNAL OF GASTROENTEROLOGY (2020)
Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives
Natascha Roehlen et al.
CELLS (2020)
Liver fibrosis: Pathophysiology, pathogenetic targets and clinical issues
Maurizio Parola et al.
MOLECULAR ASPECTS OF MEDICINE (2019)
TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis-Updated 2019
Bedair Dewidar et al.
CELLS (2019)
Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial
Zobair M. Younossi et al.
LANCET (2019)
Induction of cytochrome P450 4A14 contributes to angiotensin II-induced renal fibrosis in mice
Yunfeng Zhou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE (2018)
Liver fibrosis
M. Merve Aydin et al.
TURKISH JOURNAL OF GASTROENTEROLOGY (2018)
High-fat diet-induced obesity and insulin resistance in CYP4a14(-/-) mice is mediated by 20-HETE
Ankit Gilani et al.
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2018)
Cholestatic liver diseases: new targets, new therapies
Priscila Santiago et al.
THERAPEUTIC ADVANCES IN GASTROENTEROLOGY (2018)
Small Heterodimer Partner Regulates Circadian Cytochromes p450 and Drug-Induced Hepatotoxicity
Tianpeng Zhang et al.
THERANOSTICS (2018)
Ablation of cytochrome P450 omega-hydroxylase 4A14 gene attenuates hepatic steatosis and fibrosis
Xiaoyan Zhang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2017)
Management Strategies for Liver Fibrosis
Alejandra Altamirano-Barrera et al.
ANNALS OF HEPATOLOGY (2017)
Farnesoid X Receptor Protects against Kidney Injury in Uninephrectomized Obese Mice
Zhibo Gai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2016)
Recent advancement of molecular mechanisms of liver fibrosis
Ekihiro Seki et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Induction of experimental obstructive cholestasis in mice
C. G. Tag et al.
LABORATORY ANIMALS (2015)
Liver Fibrosis: Causes and Methods of Assessment, A Review
Ali Erfani Karimzadeh Toosi
ROMANIAN JOURNAL OF INTERNAL MEDICINE (2015)
Experimental liver fibrosis research: update on animal models, legal issues and translational aspects
Christian Liedtke et al.
FIBROGENESIS & TISSUE REPAIR (2013)
The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases
Xizhen Xu et al.
ADVANCED DRUG DELIVERY REVIEWS (2011)
Human cytochrome P450 family 4 enzymes: Function, genetic variation and regulation
Mei-Hui Hsu et al.
DRUG METABOLISM REVIEWS (2007)
The nuclear receptor SHP mediates inhibition of hepatic stellate cells by FXR and protects against liver fibrosis
S Fiorucci et al.
GASTROENTEROLOGY (2004)
分享论文
